Peter is an MD, PhD and currently works at Curamach Gene Therapy. He takes part in pre-clinical gene therapy studies on various mutant mouse models. Their team use the safe (non-integrating) and stable artificial chromosome expression (ACE) system instead of viral vectors for gene delivery. Peter is also an enthusiastic computer hacker and open-source software advocate.
